PPARδ mediates IL15 metabolic actions in myotubes: Effects of hyperthermia

International Journal of Molecular Medicine

Volumn 24, Issue 1, 2009, Pages 63-68

  Fuster, Gemma ^a,b   Busquets, Sílvia ^a   Figueras, Maite ^a   Ametller, Elisabet ^a   De Oliveira, Cibely Cristine Fontes ^a   Oliván, Mireia ^a   Grimaldi, Paul A ^c   Argilés, Josep M ^a   López Soriano, Francisco J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CENTRE DE BIOCHIMIE   (France)

Author keywords

IL15; PPAR ; Protein hypercatabolism

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; INTERLEUKIN 15; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; THIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE FUNCTION; GENE OVEREXPRESSION; HYPERTHERMIA; LIPID PEROXIDATION; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEAT; METABOLISM; MUTATION; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; CELL LINE; HOT TEMPERATURE; INTERLEUKIN-15; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUTATION; PPAR DELTA; PROTEIN BIOSYNTHESIS; THIAZOLES;

EID: 67649531209     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000207     Document Type: Article

References (31)

1. Argilés JM, Alvarez B and López-Soriano FJ: The metabolic basis of cancer cachexia. Med Res Rev 17: 477-498, 1997.
2. Argilés JM, Moore-Carrasco R, Fuster G, Busquets S and López-Soriano FJ: Cancer cachexia: the molecular mechanisms. Int J Biochem Cell Biol 35: 405-409, 2003.
3. Argilés JM, Busquets S and López-Soriano FJ: The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 293: 1145-1152, 2002.
4. Guttridge DC, Mayo MW, Madrid LV, Wang CY and Baldwin AS Jr: NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289: 2363-2366, 2000.
5. Wyke SM, Russell ST and Tisdale MJ: Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br J Cancer 91: 1742-1750, 2004.
6. Penner G, Gang G, Sun X, Wray C and Hasselgren PO: C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle. Am J Physiol 282: R439-R444, 2002.
7. Costelli P, Muscaritoli M, Bossola M, Moore-Carrasco R, Crepaldi S, Grieco G, Autelli R, Bonelli G, Pacelli F, Lopez-Soriano FJ, Argilés JM, Doglietto GB, Baccino FM and Rossi Fanelli F: Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. Int J Oncol 26: 1663-1668, 2005.
8. Moore-Carrasco R, García-Martínez C, Busquets S, Ametller E, Barreiro E, López-Soriano FJ and Argilés JM: The AP-1/ CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia. FEBS Lett 580: 691-696, 2006.
9. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P and Muscat GE: The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17: 2477-2493, 2003.
10. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J and Staels B: Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580, 1998.
11. Ferré P: The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53: S43-S50, 2004.
12. Grimaldi PA: Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment? Biochimie 87: 5-8, 2005.
13. Carbó N, López-Soriano J, Costelli P, Busquets S, Alvarez B, Baccino FM, Quinn LS, López-Soriano FJ and Argilés JM: Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer 83: 526-531, 2000.
14. Quinn LS, Anderson BG, Drivdahl RH, Alvarez B and Argilés JM: Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res 280: 55-63, 2002.
15. Carbó N, López-Soriano J, Costelli P, Alvarez B, Busquets S, Baccino FM, Quinn LS, López-Soriano FJ and Argilés JM: Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta 1526: 17-24, 2001.
16. Alvarez B, Carbó N, López-Soriano J, Drivdahl RH, Busquets S, López-Soriano FJ, Argilés JM and Quinn LS: Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochim Biophys Acta 1570: 33-37, 2002.
17. Quinn LS, Strait-Bodey L, Anderson BG, Argiles JM and Havel PJ: Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int 29: 449-457, 2005.
18. Almendro V, Busquets S, Ametller E, Carbó N, Figueras M, Fuster G, Argilés JM and López-Soriano FJ: Effects of interleukin-15 on lipid oxidation: disposal of an oral [(14)C]-triolein load. Biochim Biophys Acta 1761: 37-42, 2006.
19. Bastie C, Luquet S, Holst D, Jehl-Pietri C and Grimaldi PA: Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation. J Biol Chem 275: 38768-38773, 2000.
20. Holst D, Luquet S, Kristiansen K and Grimaldi PA: Roles of peroxisome proliferator-activated receptors delta and gamma in myoblast transdifferentiation. Exp Cell Res 288: 168-176, 2003.
21. Alvarez B, Quinn LS, Busquets S, López-Soriano FJ and Argilés JM: Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism. Eur Cytokine Netw 12: 399-410, 2001.
22. Smith HJ, Khal J and Tisdale MJ: Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid. Biochem Biophys Res Commun 332: 83-88, 2005.
23. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
24. Fuster G, Busquets S, Ametller E, Olivan M, Almendro V, De Oliveira CC, Figueras M, López-Soriano FJ and Argilés JM: Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists. Cancer Res 67: 6512-6519, 2007.
25. Marber MS: Stress proteins and myocardial protection. Clin Sci (Lond) 86: 375-381, 1994.
26. Schuler M, Ali F, Chambon C, Duteil D, Bornert JM, Tardivel A, Desvergne B, Wahli W, Chambon P and Metzger D: PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4: 407-414, 2006.
27. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL and Spiegelman BM: PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103: 16260-16265, 2006.
28. Busquets S, Figueras M, Almendro V, López-Soriano FJ and Argilés JM: Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine. Biochim Biophys Acta 1760: 1613-1617, 2006.
29. López-Soriano J, Carbó N, Almendro V, Figueras M, Ribas V, Busquets S, López-Soriano FJ and Argilés JM: Rat liver lipogenesis is modulated by interleukin-15. Int J Mol Med 13: 817-819, 2004.
30. Almendro V, Carbó N, Busquets S, López-Soriano J, Figueras M, Ametller E, Argilés JM and López-Soriano FJ: Interleukin-15 decreases lipid intestinal absorption. Int J Mol Med 15: 963-967, 2005.
31. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M and Grimaldi PA: Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17: 2299-2301, 2003.